US pushes for small medtech innovator tax breaks
This article was originally published in Clinica
Executive Summary
While the US medical technology industry continues to battle against the 2.3% tax on sales of devices − now five months into collection and approaching the $500m threshold − it has also joined a coalition that seeks a better tax regime for pre-revenue companies.